Ensuring risk management and high-quality products for customers.
Working with the right innovation and manufacturing partner, with the correct regulatory accreditation is critical for continued and reliable market access and long-term sustainable growth.
At Lipa, we are proud holders of Therapeutic Goods certification, and all manufacturing is conducted in accordance with the Therapeutic Goods Act and under GMP Licence with the TGA. We hold this certification for both lower risk medicines listed on the Australian Register of Therapeutic Goods, as well as Higher Risk medicines which must be registered on the Australian Register of Therapeutic Goods.
Both our Innovation Product Development and Regulatory teams work closely with the TGA to ensure that we are up to date with all the required regulations under Australian law and any changes that may be occurring within the regulations.
Once a product is launched on the market, products must continue to comply with regulations and may be selected for post-market reviews.




